<?xml version="1.0" encoding="UTF-8"?>

<MedicinalProductDefinition xmlns="http://hl7.org/fhir">
  <id value="cfsb1639230697840"/>
  <text>
    <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative</b></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource "cfsb1639230697840" </p></div><p><b>identifier</b>: id: EU/1/17/1201/004 (OFFICIAL)</p><p><b>type</b>: Marketing Authorisation <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (#/#100000072062)</span></p><p><b>domain</b>: Human use <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (#/#100000000012)</span></p><p><b>version</b>: 1</p><p><b>status</b>: Active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://build.fhir.org/codesystem-publication-status.html">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2015-02-07T13:28:17Z</p><p><b>description</b>: Skilarence 120 mg; Each gastro-resistant tablet contains 120 mg dimethyl fumarate</p><p><b>route</b>: Oral use <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (#/#100000073619)</span></p><p><b>indication</b>: for the treatment of moderate to severe plaque psoriasis</p><p><b>legalStatusOfSupply</b>: Medicinal product subject to medical prescription <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (#/#100000072084)</span></p><p><b>classification</b>: Other immunosuppressants <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (#L04AX07)</span>, Plaque psoriasis <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (#/#100000116590)</span></p><blockquote><p><b>name</b></p><p><b>productName</b>: Skilarence (dimethyl fumarate) 120 mg gastro-resistant tablet</p><p><b>type</b>: Full name <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (#/#220000000001)</span></p><h3>NameParts</h3><table class="grid"><tr><td>-</td><td><b>Part</b></td><td><b>Type</b></td></tr><tr><td>*</td><td>gastro-resistant tablet</td><td>Pharmaceutical dose form part <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (#/#220000000005)</span></td></tr></table><h3>CountryLanguages</h3><table class="grid"><tr><td>-</td><td><b>Country</b></td><td><b>Jurisdiction</b></td><td><b>Language</b></td></tr><tr><td>*</td><td>European Union <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (unknown#eu)</span></td><td>European Union <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (unknown#eu)</span></td><td>English <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/3.0.0/CodeSystem-v3-ietf3066.html">Tags for the Identification of Languages</a>#en)</span></td></tr></table></blockquote></div>
  </text>
  <identifier>
    <use value="official"/>
    <system value="https://spor.ema.europa.eu/pmswi/#/"/>
    <value value="EU/1/17/1201/004"/>
  </identifier>
  <type>
    <coding>
      <system value="https://spor.ema.europa.eu/rmswi/"/>
      <code value="/#100000072062"/>
    </coding>
    <text value="Marketing Authorisation"/>
  </type>
  <domain>
    <coding>
      <system value="https://spor.ema.europa.eu/rmswi/"/>
      <code value="/#100000000012"/>
    </coding>
    <text value="Human use"/>
  </domain>
  <version value="1"/>
  <status>
    <coding>
      <system value="http://hl7.org/fhir/publication-status"/>
      <code value="active"/>
      <display value="Active"/>
    </coding>
  </status>
  <statusDate value="2015-02-07T13:28:17Z"/>
  <description value="Skilarence 120 mg; Each gastro-resistant tablet contains 120 mg dimethyl fumarate"/>
  <route>
    <coding>
      <system value="https://spor.ema.europa.eu/rmswi/"/>
      <code value="/#100000073619"/>
    </coding>
    <text value="Oral use"/>
  </route>
  <indication value="for the treatment of moderate to severe plaque psoriasis"/>
  <legalStatusOfSupply>
    <coding>
      <system value="https://spor.ema.europa.eu/rmswi/"/>
      <code value="/#100000072084"/>
    </coding>
    <text value="Medicinal product subject to medical prescription"/>
  </legalStatusOfSupply>
  <classification>
    <coding>
      <system value="https://www.whocc.no/atc_ddd_index/"/>
      <code value="L04AX07"/>
    </coding>
    <text value="Other immunosuppressants"/>
  </classification>
  <classification>
    <coding>
      <system value="https://spor.ema.europa.eu/rmswi/"/>
      <code value="/#100000116590"/>
    </coding>
    <text value="Plaque psoriasis"/>
  </classification>
  <name>
    <productName value="Skilarence (dimethyl fumarate) 120 mg gastro-resistant tablet"/>
    <type>
      <coding>
        <system value="https://spor.ema.europa.eu/rmswi/"/>
        <code value="/#220000000001"/>
      </coding>
      <text value="Full name"/>
    </type>
    <namePart>
      <part value="gastro-resistant tablet"/>
      <type>
        <coding>
          <system value="https://spor.ema.europa.eu/rmswi/"/>
          <code value="/#220000000005"/>
        </coding>
        <text value="Pharmaceutical dose form part"/>
      </type>
    </namePart>
    <countryLanguage>
      <country>
        <coding>
          <system value="urn:iso:std:iso:3166"/>
          <code value="eu"/>
        </coding>
        <text value="European Union"/>
      </country>
      <jurisdiction>
        <coding>
          <system value="urn:iso:std:iso:3166"/>
          <code value="eu"/>
        </coding>
        <text value="European Union"/>
      </jurisdiction>
      <language>
        <coding>
          <system value="urn:ietf:bcp:47"/>
          <code value="en"/>
        </coding>
        <text value="English"/>
      </language>
    </countryLanguage>
  </name>
</MedicinalProductDefinition>